These effects often diminish with continued use
Postprandial gallbladder emptying in patients with type 2 diabetes: potential implications for bile-induced secretion of glucagon-like peptide 1
Patients taking tirzepatide were matched at a 1:1 ratio with patients taking a placebo
Retatrutide and High Blood Pressure: Evidence, Cautions, and UK Guidance Retatrutide and high blood pressure is an emerging area of clinical interest, as this investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously has shown modest blood pressure reductions in early Phase 2 trials
This indicates the peptide has undergone extensive denaturation, likely from either freeze-thaw damage or prolonged exposure above 8C
From a clinical perspective, the decision to use cannabis whilst taking Ozempic involves individual risk assessment